Lv4
580 积分 2023-11-04 加入
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
1天前
待确认
EAACI Biologicals Guidelines—Recommendations for severe asthma
1天前
待确认
[Chinese expert consensus on the use of Omalizumab in allergic asthma (2021 version)]
1天前
待确认
[Chinese guidelines for emergency management of bleeding in hemophilia patients (2024)]
3个月前
已完结
[Annual therapeutic advances in advanced non-small cell lung cancer in 2024]
4个月前
已完结
Tarlatamab: the promising immunotherapy on its way from the lab to the clinic
5个月前
已完结
Recent advances and future strategies in first-line treatment of ES-SCLC
5个月前
已完结
[Recommendations for the diagnosis and treatment of IgG4-related disease in China]
6个月前
已完结
[Recommendations of diagnosis and treatment of polyarteritis nodosa]
8个月前
已完结
[Guidelines on the diagnosis and management of primary biliary cholangitis (2021)]
8个月前
已完结
皖公网安备34019202002308
